An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.

Volume: 65, Issue: 4, Pages: 1196 - 1205
Published: Apr 1, 2017
Abstract
Although surveillance ultrasound and alpha fetoprotein (AFP) tests have minimal direct harm, downstream harms from follow-up tests must be weighed against surveillance benefits when determining the value of hepatocellular carcinoma (HCC) screening programs. Our study's aims were to characterize prevalence and correlates of surveillance benefits and harms in cirrhosis patients undergoing HCC surveillance. We conducted a retrospective cohort study...
Paper Details
Title
An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.
Published Date
Apr 1, 2017
Journal
Volume
65
Issue
4
Pages
1196 - 1205
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.